Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurence Booth

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Cancer Biology & Therapy|December 20, 2013
HDAC inhibitors enhance the lethality of low dose salinomycin in parental and stem-like GBM cellsLaurence Booth, Jane L Roberts, Adam Conley, et al.
Journal of Cellular Physiology|March 5, 2015
OSU-03012 and Viagra Treatment Inhibits the Activity of Multiple Chaperone Proteins and Disrupts the Blood-Brain Barrier: Implications for Anti-Cancer TherapiesLaurence Booth, Jane L Roberts, Mehrad Tavallai, et al.
Biochemical Pharmacology|September 23, 2020
AR12 (OSU-03012) suppresses GRP78 expression and inhibits SARS-CoV-2 replicationJonathan O Rayner, Rosemary A Roberts, Jin Kim, et al.
Cancer Biology & Therapy|January 16, 2018
The irreversible ERBB1/2/4 inhibitor neratinib interacts with the BCL-2 inhibitor venetoclax to kill mammary cancer cellsLaurence Booth, Jane L Roberts, Francesca Avogadri-Connors, et al.
Oncotarget|November 23, 2017
HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody <i>in vivo</i>Laurence Booth, Jane L Roberts, Andrew Poklepovic, et al.
Cancer Biology & Therapy|March 25, 2015
Differential regulation of autophagy and cell viability by ceramide speciesNichola Cruickshanks, Jane L Roberts, M Danielle Bareford, et al.
Oncotarget|September 7, 2019
Correction: HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody <i>in vivo</i>Laurence Booth, Jane L Roberts, Andrew Poklepovic, et al.
Journal of Cellular Physiology|February 24, 2015
Nexavar/Stivarga and viagra interact to kill tumor cellsMehrad Tavallai, Hossein A Hamed, Jane L Roberts, et al.
Cancer Biology & Therapy|September 6, 2018
Palbociclib augments Neratinib killing of tumor cells that is further enhanced by HDAC inhibitionLaurence Booth, Jane L Roberts, Rumeesa Rais, et al.
Cancer Biology & Therapy|February 23, 2012
OSU-03012 suppresses GRP78/BiP expression that causes PERK-dependent increases in tumor cell killingLaurence Booth, Sophie C Cazanave, Hossein A Hamed, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Cancer Biology & Therapy|December 20, 2013
HDAC inhibitors enhance the lethality of low dose salinomycin in parental and stem-like GBM cellsLaurence Booth, Jane L Roberts, Adam Conley, et al.
Journal of Cellular Physiology|March 5, 2015
OSU-03012 and Viagra Treatment Inhibits the Activity of Multiple Chaperone Proteins and Disrupts the Blood-Brain Barrier: Implications for Anti-Cancer TherapiesLaurence Booth, Jane L Roberts, Mehrad Tavallai, et al.
Biochemical Pharmacology|September 23, 2020
AR12 (OSU-03012) suppresses GRP78 expression and inhibits SARS-CoV-2 replicationJonathan O Rayner, Rosemary A Roberts, Jin Kim, et al.
Cancer Biology & Therapy|January 16, 2018
The irreversible ERBB1/2/4 inhibitor neratinib interacts with the BCL-2 inhibitor venetoclax to kill mammary cancer cellsLaurence Booth, Jane L Roberts, Francesca Avogadri-Connors, et al.
Oncotarget|November 23, 2017
HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody <i>in vivo</i>Laurence Booth, Jane L Roberts, Andrew Poklepovic, et al.
Cancer Biology & Therapy|March 25, 2015
Differential regulation of autophagy and cell viability by ceramide speciesNichola Cruickshanks, Jane L Roberts, M Danielle Bareford, et al.
Oncotarget|September 7, 2019
Correction: HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody <i>in vivo</i>Laurence Booth, Jane L Roberts, Andrew Poklepovic, et al.
Journal of Cellular Physiology|February 24, 2015
Nexavar/Stivarga and viagra interact to kill tumor cellsMehrad Tavallai, Hossein A Hamed, Jane L Roberts, et al.
Cancer Biology & Therapy|September 6, 2018
Palbociclib augments Neratinib killing of tumor cells that is further enhanced by HDAC inhibitionLaurence Booth, Jane L Roberts, Rumeesa Rais, et al.
Cancer Biology & Therapy|February 23, 2012
OSU-03012 suppresses GRP78/BiP expression that causes PERK-dependent increases in tumor cell killingLaurence Booth, Sophie C Cazanave, Hossein A Hamed, et al.
Pageof 10